medac GmbH
Dr. Mimount El Aanbouri has extensive experience in the pharmaceutical industry, currently serving as Product/Project Manager for QA Operations at medac GmbH since July 2014. Prior roles include scientific staff in development at Helm AG from January 2012 to June 2014 and development and pharmacovigilance staff at neuraxpharm Arzneimittel GmbH u. Co. KG from January 2010 to December 2011. Dr. El Aanbouri holds a Promotion in Neurology from The University of Göttingen (2006-2009), a Diplom in Biochemistry from Universität Witten/Herdecke (2002-2006), and a Vordiplom in General Biology from the University of Düsseldorf (1999-2002).
medac GmbH
We are a privately held, medium-sized global pharmaceutical and diagnostics company based in Germany. For more than 50 years we have been committed to high quality products, reliable supply and individual customer services. Today, over 2.000 medac employees worldwide are working together to supply more than 90 countries with our products. Since our foundation we have been specialising in the treatment of oncological, haematological, urological, and autoimmune diseases. Today, we are a leading specialist supplier in oncology and rheumatology. We combine the innovative power of a researching pharmaceutical company with the efficiency of a generics manufacturer and offer both therapeutics and diagnostics. Always putting the needs of patients and healthcare professionals first, we are committed to the refinement of established and the development of new products with additional benefits for patients in specific niche indications with high therapeutic needs.